WBB Securities Initiates Coverage On CytoSorbents with Speculative Buy Rating, Announces Price Target of $9.5
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsInitiationPrice Target
WBB Securities analyst Karen Sterling initiates coverage on CytoSorbents (NASDAQ:CTSO) with a Speculative Buy rating and announces Price Target of $9.5.
WBB Securities analyst Karen Sterling initiates coverage on CytoSorbents (NASDAQ:CTSO) with a Speculative Buy rating and announces Price Target of $9.5.